Skip to main content

Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping with Hodgkin Lymphoma

Trial Status: Active

This trial studies how well a mind-body intervention works in improving overall quality of life in adolescents and young adults with Hodgkin lymphoma. A meditation based mind-body intervention may help lower distress, depressive symptoms, and anxiety in adolescents and young adults coping with Hodgkin lymphoma.

Inclusion Criteria

  • Participants diagnosed within 6 months with stage I-IV HL
  • Eastern Cooperative Oncology Group (ECOG) performance status of 2 or below
  • Having access to the internet
  • Able to read, write and speak English

Exclusion Criteria

  • Major psychiatric or cognitive deficits that would impede the completion of self-report instruments as deemed by the clinical team
  • Regular (self-defined) participation in psychotherapy or a formal cancer support group


M D Anderson Cancer Center
Status: ACTIVE
Contact: Kathrin Milbury
Phone: 713-745-2868


I. Examine the feasibility of the mind-body intervention in adolescents and young adults (AYAs) with Hodgkin lymphoma (HL).


I. Establish the initial intervention efficacy regarding psychological distress and cancer symptoms (tertiary objective) relative to an attention control (AC) group.


I. Explore mediation (e.g., mindfulness, compassion, social connection, inflammatory processes) and moderation (e.g., demographic and medical factors) of the intervention effects.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP I: Patients attend meditation group sessions over 75 minutes once weekly for up to 5 weeks.

GROUP II: Patients attend educational group sessions over 75 minutes once weekly for up to 5 weeks.

After completion of study intervention, patients are followed at 6 and 12 weeks.

Trial Phase Phase NA

Trial Type Supportive care

Lead Organization
M D Anderson Cancer Center

Principal Investigator
Kathrin Milbury

  • Primary ID 2019-0282
  • Secondary IDs NCI-2019-05846
  • ID NCT04270266